Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults

NCT00741806 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: GHB04L1
OTHER: Placebo

Sponsor

AVIR Green Hills Biotechnology AG

Collaborators

[object Object]